Author:
Yang Li,Huang Jianhua,Ren Xiubao,Gorska Agnieszka E.,Chytil Anna,Aakre Mary,Carbone David P.,Matrisian Lynn M.,Richmond Ann,Lin P. Charles,Moses Harold L.
Subject
Cancer Research,Cell Biology,Oncology
Reference60 articles.
1. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor;Ahuja;J. Biol. Chem.,1996
2. TGF-beta signaling in cancer—A double-edged sword;Akhurst;Trends Cell Biol.,2001
3. Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer;Almand;J. Immunol.,2001
4. Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats;Auten;J. Pharmacol. Exp. Ther.,2001
5. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer;Bagadi;Breast Cancer Res. Treat.,2007
Cited by
823 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献